image
Erasca, Inc. ERAS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.21
-4.69 %
$ 343 M
Market Cap
-2.14
P/E
Price Target Average
285.67%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
21.01%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Erasca, Inc.
image
Wall Street analysts predict an average 1-year price target for ERAS of $4.67 , with forecasts ranging from a low of $3 to a high of $6 .
ERAS Lowest Price Target Wall Street Target
3 USD 147.93%
ERAS Average Price Target Wall Street Target
4.67 USD 285.67%
ERAS Highest Price Target Wall Street Target
6 USD 395.87%
Price
Max Price Target
Min Price Target
Average Price Target
6666555544443333222211Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25May '25May '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26May '26May '26
REVENUE FORECAST

Revenue Forecast Chart ERAS

image
$160.0m$160.0m$140.0m$140.0m$120.0m$120.0m$100.0m$100.0m$80.0m$80.0m$60.0m$60.0m$40.0m$40.0m$20.0m$20.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ERAS

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ERAS

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)($1.4b)($1.4b)($1.6b)($1.6b)($1.8b)($1.8b)20232023202420242025202520262026202720272028202820292029